[ALNY] QoQ Quarter Result on 31-Dec-2012 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -218.88%
YoY- -334.79%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 8,991 8,687 18,642 8,495 16,759 20,884 20,587 -42.40%
PBT -31,956 -21,053 -9,575 -72,760 -19,502 -12,956 -11,368 99.05%
Tax -2,270 -2,884 -562 -10,572 -2,543 -2,855 -414 210.62%
NP -29,686 -18,169 -9,013 -62,188 -19,502 -12,956 -11,368 89.52%
Tax Rate - - - - - - - -
Total Cost 38,677 26,856 27,655 70,683 36,261 33,840 31,955 13.56%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin -330.17 -209.15 -48.35 -732.05 -116.37 -62.04 -55.22 229.07%
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
EPS -0.48 -0.29 -0.15 -1.20 -0.38 -0.25 -0.25 54.41%
EPS Diluted -0.48 -0.29 -0.15 -1.20 -0.38 -0.25 -0.25 54.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.